menu search

SGIOY / Shionogi: Likely The Last Viable COVID Play

Shionogi: Likely The Last Viable COVID Play
Xocova is an approved-in-Japan COVID antiviral. Other COVID investments are causing valuations to fall as their opportunities subside. Read More
Posted: Mar 3 2023, 22:04
Author Name: Seeking Alpha
Views: 102590

SGIOY News  

Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 14, 2023

Shionogi & Co., Ltd. (SGIOF) Q1 2023 Earnings Call Transcript

Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call May 10, 2023 10:00 PM ET Company Participants Yoshimasa Kyokawa - Investor Relatio more_horizontal

Shionogi: Likely The Last Viable COVID Play

By Seeking Alpha
March 3, 2023

Shionogi: Likely The Last Viable COVID Play

Xocova is an approved-in-Japan COVID antiviral. Other COVID investments are causing valuations to fall as their opportunities subside. more_horizontal


Search within

Pages Search Results: